marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Panbela Therapeutics Balance Sheet 2011-2024 | PBLA
Annual Balance Sheet Panbela Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.62 M | 3.91 M | - | -9.02 M | -2.33 M | -1.06 M | 1.67 M | 2.84 M | 2.4 M | 413 K | 523 K | 475 K | 520 K |
Long Term Debt |
4.19 M | 5.19 M | - | - | - | - | 286 K | - | 3.08 M | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | 286 K | 14 K | 294 K | - | - | - | - | - |
Total Non Current Liabilities |
4.19 M | 5.19 M | - | - | - | - | 286 K | - | 3.11 M | 2.41 K | 6.46 K | 8.25 K | 3.83 K |
Total Current Liabilities |
12.3 M | 7.83 M | 2.66 M | 1.36 M | 1.76 M | 1.63 M | 4.17 M | 5.52 M | 1.38 M | 616 K | 664 K | 644 K | - |
Total Liabilities |
16.5 M | 13 M | 2.66 M | 1.36 M | 1.76 M | 1.63 M | 4.46 M | 5.52 M | 4.49 M | 618 K | 670 K | 652 K | 659 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | 18.9 K | 33 K | 27 K | 24.5 K |
Retained Earnings |
-125 M | -91.1 M | -56.2 M | -46 M | -41.3 M | -35.1 M | -29.2 M | -18.8 M | -13.7 M | -14 M | -13.9 M | -13.7 M | -13.9 M |
Total Assets |
11.8 M | 4.98 M | 12.9 M | 9.81 M | 3.14 M | 1.9 M | 767 K | 877 K | 1.81 M | 407 K | 532 K | 611 K | 254 K |
Cash and Cash Equivalents |
2.58 M | 1.28 M | 11.9 M | 9.02 M | 2.45 M | 1.4 M | 152 K | 438 K | 925 K | 1.65 M | 58.8 K | 111 K | 47.9 K |
Book Value |
-4.71 M | -8.05 M | 10.2 M | 8.45 M | 1.38 M | 268 K | -3.69 M | -4.64 M | -2.68 M | -211 K | -138 K | -40.8 K | -405 K |
Total Shareholders Equity |
-4.71 M | -8.05 M | 10.2 M | 8.45 M | 1.38 M | 268 K | -3.69 M | -4.64 M | -2.68 M | -1.32 M | -138 K | -40.8 K | -405 K |
All numbers in USD currency
Quarterly Balance Sheet Panbela Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
3.19 M | 3.19 M | 3.19 M | 4.19 M | 4.19 M | 4.19 M | 4.19 M | 5.19 M | 5.19 M | 5.19 M | - | - | - | - | - | - | 742 K | - | - | - | 742 K | 742 K | - | - | - | - | 250 K | 286 K | 286 K | 286 K | 286 K | - | 292 K | 291 K | 289 K | 287 K | 287 K | 287 K | 287 K | 300 K | 300 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
3.19 M | 3.19 M | 3.19 M | 4.19 M | 4.19 M | 4.19 M | 4.19 M | 5.19 M | 5.19 M | 5.19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 250 K | 286 K | 286 K | 286 K | 286 K | - | 3.07 M | 3.06 M | 3.05 M | 3.04 M | 3.04 M | 3.04 M | 3.04 M | 3.33 M | 3.33 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
23.3 M | 20 M | 13.7 M | 16.5 M | 13.1 M | 14.7 M | 13.9 M | 13 M | 13.1 M | 11.4 M | - | 2.66 M | - | - | - | 1.36 M | - | - | - | 1.76 M | 1.43 M | 1.46 M | - | 1.63 M | 1.63 M | 1.63 M | - | - | - | - | - | - | - | - | - | - | - | 569 K | 641 K | 618 K | 674 K | 670 K | 618 K | 670 K | 670 K | 670 K | 670 K | 652 K | 652 K | 652 K | 652 K | 659 K | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.52 K | 14.3 K | 18.9 K | 28.4 K | 11.9 K | 18.9 K | 33 K | 33 K | 33 K | 33 K | 27 K | 27 K | 27 K | 27 K | 24.5 K | - | - | - |
Retained Earnings |
-147 M | -140 M | -133 M | -125 M | -110 M | -102 M | -96.2 M | -91.1 M | -86.4 M | -82 M | -59.8 M | -56.2 M | -52.6 M | -50.5 M | -48.3 M | -46 M | -46 M | -46 M | -46 M | -41.3 M | -41.3 M | -41.3 M | -41.3 M | -35.1 M | -35.1 M | -35.1 M | -35.1 M | -29.2 M | -29.2 M | -29.2 M | -29.2 M | -18.8 M | -18.8 M | -18.8 M | -18.8 M | -13.7 M | -13.7 M | -13.7 M | -13.7 M | -8.57 M | -8.57 M | -14 M | -14 M | -13.9 M | -13.9 M | -13.9 M | -13.9 M | -13.7 M | -13.7 M | -13.7 M | -13.7 M | -13.9 M | - | - | - |
Total Assets |
5.17 M | 9.41 M | 10.5 M | 11.8 M | 10.6 M | 19.6 M | 16.5 M | 4.98 M | 4.87 M | 6.56 M | 11.1 M | 12.9 M | 14.8 M | 7.3 M | 8.89 M | 9.81 M | 9.81 M | 9.81 M | 9.81 M | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 767 K | 767 K | 767 K | 767 K | 877 K | 877 K | 877 K | 877 K | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 2.48 M | 2.48 M | 407 K | 407 K | 532 K | 532 K | 532 K | 532 K | 611 K | 611 K | 611 K | 611 K | 254 K | - | - | - |
Cash and Cash Equivalents |
142 K | 59 K | 262 K | 2.58 M | 907 K | 7.2 M | 5.24 M | 1.28 M | 941 K | 2.53 M | 7.39 M | 11.9 M | 14.1 M | 6.4 M | 8.1 M | 9.02 M | 9.02 M | 9.02 M | 9.02 M | 2.45 M | 2.45 M | 2.45 M | 2.45 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 152 K | 152 K | 152 K | 152 K | 438 K | 438 K | 438 K | 438 K | 925 K | 925 K | 925 K | 925 K | 1.65 M | 1.65 M | 164 K | 164 K | 2.69 M | 58.8 K | 58.8 K | 58.8 K | 111 K | 111 K | 111 K | 111 K | 47.9 K | - | - | - |
Book Value |
-18.2 M | -10.6 M | -3.19 M | -4.71 M | -2.48 M | 4.8 M | 2.54 M | -8.05 M | -8.28 M | -4.84 M | 11.1 M | 10.2 M | 14.8 M | 7.3 M | 8.89 M | 8.45 M | 9.81 M | 9.81 M | 9.81 M | 1.38 M | 1.71 M | 1.69 M | 3.14 M | 268 K | 268 K | 268 K | 1.9 M | 767 K | 767 K | 767 K | 767 K | 877 K | 877 K | 877 K | 877 K | 1.73 M | 1.73 M | 1.16 M | 1.09 M | 1.86 M | 1.8 M | -263 K | -211 K | -138 K | -138 K | -138 K | -138 K | -40.8 K | -40.8 K | -40.8 K | -40.8 K | -405 K | - | - | - |
Total Shareholders Equity |
-18.2 M | -10.6 M | -3.19 M | -4.71 M | -2.48 M | 4.8 M | 2.54 M | -8.05 M | -8.28 M | -4.84 M | 6.58 M | 10.2 M | 13.5 M | 5.89 M | 7.58 M | 8.45 M | 8.45 M | 8.45 M | 8.45 M | 1.38 M | 1.38 M | 1.38 M | 1.38 M | 268 K | 268 K | 268 K | 268 K | -3.69 M | -3.69 M | -3.69 M | -3.69 M | -4.64 M | -4.64 M | -4.64 M | -4.64 M | -2.68 M | -2.68 M | -2.68 M | -2.68 M | -1.32 M | -1.32 M | -211 K | -211 K | 1.41 M | -138 K | -138 K | -138 K | -40.8 K | -40.8 K | -40.8 K | -40.8 K | -405 K | - | - | - |
All numbers in USD currency